Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tecentriq
Tecentriq
Move over, AstraZeneca. Pfizer and Merck KGaA are the newest bladder cancer drugmakers in town
Fierce Pharma
Wed, 05/10/17 - 09:31 am
Pfizer
Merck KGaA
AstraZeneca
Bavencio
avelumab
bladder cancer
Imfinzi
FDA
Opdivo
Tecentriq
Roche's Tecentriq wins FDA OK as first-line treatment in bladder cancer
Fierce Pharma
Tue, 04/18/17 - 09:00 pm
Roche
Tecentriq
bladder cancer
FDA
4 Reasons Why Roche Will Have the Best Growth in Big Pharma... and 1 Reason Why It Won't
Motley Fool
Wed, 04/12/17 - 10:33 am
Roche
Tecentriq
Perjeta
HER-2 postive breast cancer
Ocrevus
MS
multiple sclerosis
diagnostics
generics
biosimilars
3 Big Pharma Companies With the Best Pipelines
Motley Fool
Sun, 04/9/17 - 12:24 pm
JNJ
Actelion
Darzalex
Novartis
Cosentyx
Jakavi
Lucentis
Tasigna
Roche
Venclexta
Tecentriq
emicizumab
Should Merck, BMS Fear Roche's Drug Becoming The I-O King?
Seeking Alpha
Fri, 02/24/17 - 09:10 am
Merck
Bristol-Myers Squibb
Roche
immuno-oncology
Tecentriq
Roche says Phase II trial supports twin treatment for kidney cancer
Yahoo/Reuters
Sat, 02/18/17 - 02:35 pm
Roche
kidney cancer
Tecentriq
Checkpoint inhibitors set to face off in bladder cancer
BioPharma Dive
Wed, 02/8/17 - 09:48 am
bladder cancer
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
Roche
Tecentriq
AstraZeneca
durvalumab
Roche cancer drug taking bite out of Bristol's Opdivo
Yahoo/Reuters
Fri, 01/27/17 - 09:23 am
Roche
Bristol-Myers Squibb
Tecentriq
non-small cell lung cancer
Opdivo
Brace Yourself: AstraZeneca Could Be a Fourth Entrant into the PD-1/PD-L1 Drug Class
Market Realist
Mon, 11/21/16 - 11:39 am
AstraZeneca
anti-PD-L1
durvalumab
Opdivo
Keytruda
Tecentriq
Bristol-Myers Squibb
Roche
Merck
Roche flags early success for Tecentriq combos, hustles into PhIIIs
Endpoints
Mon, 11/7/16 - 09:10 pm
Tecentriq
Roche
clinical trials
melanoma
Roche's lung cancer drug wins U.S. approval
Yahoo/Reuters
Tue, 10/18/16 - 10:27 pm
Roche
lung cancer
FDA
Tecentriq
non-small cell lung cancer
Roche lung cancer drug success adds to pressure on Bristol
Yahoo/Reuters
Mon, 10/10/16 - 09:14 am
Roche
lung cancer
Tecentriq
3 Critical FDA Decisions You Can't Afford to Miss
Motley Fool
Tue, 09/27/16 - 10:13 pm
FDA
Orkambi
Vertex Pharmaceuticals
Roche
Tecentriq
Regeneron
Sanofi
Sarilumab
Roche's Tecentriq ready to compete in lung cancer
BioPharma Dive
Fri, 09/2/16 - 09:36 am
Roche
Tecentriq
non-small cell lung cancer
Epizyme partners with Roche to test cancer drug combo
BioPharma Dive
Thu, 06/23/16 - 08:22 pm
Epizyme
Roche
PDL-1 inhibitors
diffuse large B-cell lymphoma
Tecentriq
tazemetostat
New Roche med Tecentriq shines in study of untreated bladder cancer patients
Fierce Pharma
Sun, 06/5/16 - 11:52 am
Roche
Tecentriq
bladder cancer
ASCO 2016
Five Storylines To Watch At ASCO
Forbes
Tue, 05/31/16 - 11:14 am
ASCO 2016
drug pricing
Pfizer
Ibrance
breast cancer
Tecentriq
Genentech
Roche
PDL-1 inhibitors
FDA approves Roche therapy for bladder cancer
Marketwatch
Thu, 05/19/16 - 09:55 am
FDA
Roche
bladder cancer
Tecentriq
atezolizumab
Pages
« first
‹ previous
1
2
3
4
5
6
7